Weiss Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History

Weiss Asset Management’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$289K	Sell	36,488 -13,513	-27%	-$86.3K	﹤0.01%	556
2026 Q1	$290K	Hold	50,001	–	–	﹤0.01%	438
2025 Q4	$393K	Hold	50,001	–	–	0.01%	499
2025 Q3	$407K	Hold	50,001	–	–	﹤0.01%	480
2025 Q2	$234K	Hold	50,001	–	–	﹤0.01%	384
2025 Q1	$275K	Hold	50,001	–	–	0.01%	258
2024 Q4	$170K	Hold	50,001	–	–	﹤0.01%	573
2024 Q3	$143K	Hold	50,001	–	–	﹤0.01%	553
2024 Q2	$113K	Hold	50,001	–	–	﹤0.01%	232
2024 Q1	$111K	Buy	+50,001	New	+$129K	﹤0.01%	261

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Weiss Asset Management's XERS Position: Q2 2026 in Review

Weiss Asset Management reduced its Xeris Biopharma Holdings (XERS) stake by 27% in Q2 2026, selling an estimated $86.3K and leaving 36,488 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #556.

Weiss Asset Management first reported a position in XERS in Q1 2024 and has held it in 10 quarters since. The position peaked at $407K in Q3 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

Weiss Asset Management held 36,488 shares of Xeris Biopharma Holdings worth $289K as of Q2 2026.
Weiss Asset Management sold 13,513 Xeris Biopharma Holdings shares in Q2 2026, an estimated $86.3K.
Xeris Biopharma Holdings made up ﹤0.01% of Weiss Asset Management's portfolio in Q2 2026, its #556 holding.
Weiss Asset Management first reported a position in Xeris Biopharma Holdings in Q1 2024 and has held it in 10 quarters since.
Weiss Asset Management's Xeris Biopharma Holdings position peaked at $407K in Q3 2025.
240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.